Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

Sunday, May 12, 2019 - 04:40 in Health & Medicine

The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net